BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2000
View Archived Issues
Aurora acquires Quorum Sciences
Read More
Antex licenses lantibiotics with promise for antibiotic-resistant bacteria
Read More
Complete analysis of data from Neotrofin phase II trial
Read More
Vertex expands product pipeline
Read More
Posaconazole active against histoplasmosis in immunocompromised animals
Read More
Cryptococcus neoformans potently inhibited by ravuconazole in recent in vitro study
Read More
ABT-773 effective against disseminated MAC infection in vivo
Read More
Pharmacokinetics, disposition and metabolism of new hepatic antiinflammatory TA-510
Read More
Chemotherapeutic potential of competitive glyoxalase I inhibitor evaluated in tumor-bearing mice
Read More
E-6060, a potential new therapy for antibody-dependent autoimmune diseases
Read More
Vivus begins patient enrollment for female sexual dysfunction trial
Read More
Antisoma licenses thioplatin from German cancer center
Read More
Immunotherapy with beta-alethine useful in minimal residual disease
Read More
Safe new agents from Ajinomoto with potential in irritable bowel syndrome
Read More
Substituted aza-oxindoles which inhibit protein tyrosine or serine/threonine kinases
Read More
Patient enrollment begins in phase I trial of Cotara for colorectal cancer
Read More
Novo Nordisk's new potassium channel openers specifically claimed for diabetes
Read More
Inflammatory cytokine-reducing compounds designed at Celgene
Read More
Novel GH secretagogues claimed by BMS
Read More
Boehringer Ingelheim presents new series of inhibitors of signal transduction
Read More
Subtype-selective estrogen receptor modulators described by Signal, AxyS
Read More
BioChem Pharma to acquire CliniChem
Read More
Zevalin effective and safe in refractory, heavily pretreated NHL patients
Read More
License to new drug delivery technology obtained by Kos
Read More
Melacine as adjuvant therapy in melanoma: phase III data reported at SBT meeting
Read More